PE’s interest in pest control grows; Platinum Equity in generic pharma deal

Platinum Equity takes a controlling stake in Inventia's generic pharma business.

30 August 2024•4 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.